These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27989243)

  • 1. Management of Rabies Prophylaxis for Potential Bat Exposures in a Level III Neonatal Intensive Care Unit.
    Bailey AL; Quick RD; Dixon J; Hauger SB
    Infect Control Hosp Epidemiol; 2017 Apr; 38(4):483-485. PubMed ID: 27989243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-exposure rabies prophylaxis for mass bat exposures: Case series and systematic review.
    Choe YJ; Teevan B; Smit M; Quilliam D; Bandy U; Mermel L
    Zoonoses Public Health; 2020 Jun; 67(4):331-341. PubMed ID: 32347667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Travel and non-travel associated rabies post exposure treatment in New South Wales residents, Australia, 2007-2011: a cross-sectional analysis.
    Kardamanidis K; Cashman P; Durrheim DN
    Travel Med Infect Dis; 2013; 11(6):421-6. PubMed ID: 24211239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exposure to rabies during pregnancy.
    Windrim C; McGeer AJ; Murphy KE
    CMAJ; 2018 Oct; 190(43):E1281-E1283. PubMed ID: 30373741
    [No Abstract]   [Full Text] [Related]  

  • 5. Pre-exposure vaccination against rabies: are we being left in the lurch?
    Dawson J
    Vet Rec; 2013 Oct; 173(14):348-9. PubMed ID: 24123447
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk of rabies transmission and adverse effects of postexposure prophylaxis in health care workers exposed to a fatal case of human rabies.
    Mahamat A; Meynard JB; Djossou F; Dussart P; Demar M; Fontanella JM; Hommel D; Flamand C; Bourhy H; Spiegel A
    Am J Infect Control; 2012 Jun; 40(5):456-8. PubMed ID: 21906845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on human rabies in a dog- and fox-rabies-free country.
    Stahl JP; Gautret P; Ribadeau-Dumas F; Strady C; Le Moal G; Souala F; Maslin J; Fremont B; Bourhy H
    Med Mal Infect; 2014 Jul; 44(7):292-301. PubMed ID: 25011930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-exposure rabies prophylaxis in humans exposed to animals in Lublin province (Eastern Poland) in 2012-2015 - A retrospective study.
    Krzowska-Firych J; Tomasiewicz K; Kozøowska A
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-6. PubMed ID: 28166482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of chromatographically purified Vero cell rabies vaccine for intradermal pre- and post-exposure rabies prophylaxis.
    Tantawichien T; Sibunruang S; Tantawichien T; Angsanakul J; Benjavongkulchai M; Limsuwan K; Udomchaisakul P; Khomvilai S; Sitprija V
    Expert Rev Vaccines; 2014 Dec; 13(12):1593-601. PubMed ID: 25315021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human rabies post exposure prophylaxis in Bhutan, 2005-2008: trends and risk factors.
    Tenzin ; Dhand NK; Ward MP
    Vaccine; 2011 May; 29(24):4094-101. PubMed ID: 21497633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rabies post-exposure prophylaxis with purified equine rabies immunoglobulin: one-year follow-up of patients with laboratory-confirmed category III rabies exposure in the Philippines.
    Quiambao BP; Dy-Tioco HZ; Dizon RM; Crisostomo ME; Teuwen DE
    Vaccine; 2009 Nov; 27(51):7162-6. PubMed ID: 19925947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rabies pre-exposure vaccination of children with purified chick embryo cell vaccine (PCECV).
    Malerczyk C; Vakil HB; Bender W
    Hum Vaccin Immunother; 2013 Jul; 9(7):1454-9. PubMed ID: 23571224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postexposure prophylaxis for rabies in resource-limited/poor countries.
    Shantavasinkul P; Wilde H
    Adv Virus Res; 2011; 79():291-307. PubMed ID: 21601051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent temporary paralysis reported after human rabies post-exposure prophylaxis.
    Dato VM; Campagnolo ER; Shah DU; Bellush MJ; Rupprecht CE
    Zoonoses Public Health; 2015 May; 62(3):222-7. PubMed ID: 24995792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Immunogenicity of purified chick embryo cell rabies vaccine (VaxiRab N) administered intradermally as post exposure prophylaxis.
    Ravish HS; Vijayashankar V; Madhusudana SN; Sudarshan MK; Narayana DH; Andanaiah G; Ashwin BY; Rachana AR; Shamanna M
    Hum Vaccin Immunother; 2014; 10(8):2433-7. PubMed ID: 25424951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse events following rabies post-exposure prophylaxis: a comparative study of two different schedules and two vaccines.
    Sari T; Tulek N; Bulut C; Oral B; Tuncer Ertem G
    Travel Med Infect Dis; 2014; 12(6 Pt A):659-66. PubMed ID: 24685372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Early death" and the contraindication of vaccine during treatment of rabies.
    Willoughby RE
    Vaccine; 2009 Nov; 27(51):7173-7. PubMed ID: 19925949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Adverse Effect of the 2-1-1 Regimen for Rabies PEP in Preschool Children.
    Liu SQ; Tao XY; Yu PC; Jin CQ; Yu HJ; Chen MS; Zhu WY
    Biomed Environ Sci; 2017 May; 30(5):373-375. PubMed ID: 28549493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postexposure rabies prophylaxis completed in 1 week: preliminary study.
    Shantavasinkul P; Tantawichien T; Wilde H; Sawangvaree A; Kumchat A; Ruksaket N; Lohsoonthorn V; Khawplod P; Tantawichien T
    Clin Infect Dis; 2010 Jan; 50(1):56-60. PubMed ID: 19995217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 30 Years of rabies vaccination with Rabipur: a summary of clinical data and global experience.
    Giesen A; Gniel D; Malerczyk C
    Expert Rev Vaccines; 2015 Mar; 14(3):351-67. PubMed ID: 25683583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.